Alethea Capital Management, LLC Bristol Myers Squibb CO Transaction History

Alethea Capital Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$57.89 - $64.73 $423,465 - $473,499	7,315 New	7,315 $424,000
Q1 2023 May 15, 2023	BUY	$65.71 - $74.53 $589,090 - $668,161	8,965 New	8,965 $621,000
Q4 2020 Feb 12, 2021	SELL	$57.74 - $65.43 $605,519 - $686,164	-10,487 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$57.43 - $63.64 $879,023 - $974,073	-15,306 Reduced 59.34%	10,487 $632,000
Q2 2020 Aug 11, 2020	BUY	$54.82 - $64.09 $250,582 - $292,955	4,571 Added 21.54%	25,793 $1.52 Million
Q1 2020 May 11, 2020	BUY	$46.4 - $67.43 $984,700 - $1.43 Million	21,222 New	21,222 $1.18 Million
Q1 2019 May 06, 2019	SELL	$45.12 - $53.8 $1.21 Million - $1.45 Million	-26,873 Closed	0 $0
Q4 2018 Jan 23, 2019	BUY	$48.76 - $63.23 $1.31 Million - $1.7 Million	26,873 New	26,873 $1.4 Million
Q2 2018 Jul 17, 2018	SELL	$50.53 - $62.98 $391,708 - $488,220	-7,752 Closed	0 $0
Q1 2018 Apr 18, 2018	BUY	$59.92 - $68.98 $464,499 - $534,732	7,752 New	7,752 $490,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Alethea Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Alethea Capital Management, LLC with notifications on news.